Last quarter (Q3 2023), RxSight's total revenue was $22.20M, an increase of 75.97% from the same quarter last year. In Q3, RxSight's net income was $-12.41M. See RxSight’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 76.59M	$ 49.01M	$ 22.59M	$ 14.68M	$ 2.24M
Cost of Revenue	$ 15.72M	$ 27.68M	$ -18.08M	$ 12.97M	$ 4.06M
Gross Profit	$ 43.53M	$ 21.33M	$ 4.52M	$ 1.71M	$ -1.82M
Operating Expense	$ 52.93M	$ 84.65M	$ -57.30M	$ 37.11M	$ 44.77M
Operating Income	$ -54.22M	$ -63.32M	$ -47.77M	$ -35.41M	$ -46.59M
Net Non Operating Interest Income Expense	$ 995.00K	$ -3.43M	$ -3.63M	$ 33.00K	$ 2.28M
Other Income Expense	$ 84.69M	$ -75.00K	$ -2.72M	$ 63.00M	$ 170.55M
Pretax Income	$ -55.00M	$ -66.75M	$ -48.68M	$ 27.63M	$ 126.24M
Tax Provision	$ 51.00K	$ 9.00K	$ 8.00K	$ 57.00K	$ 24.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-
Net Income Common Stockholders	$ -55.05M	$ -66.76M	$ -48.69M	$ 3.37M	$ 26.13M
Basic EPS	$ -2.36	$ -2.41	$ -3.57	$ 0.18	$ 1.39
Diluted EPS	$ -1.72	$ -2.41	$ -3.57	$ 0.18	$ 1.39
Basic Average Shares	$ 129.46M	$ 27.66M	$ 13.63M	$ 18.78M	$ 18.78M
Diluted Average Shares	$ 129.46M	$ 27.66M	$ 13.63M	$ 18.78M	$ 18.78M
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-
Total Expenses	$ 68.65M	$ 112.32M	$ -75.38M	$ 50.08M	$ 48.83M
Net Income From Continuing And Discontinued Operation	$ -55.05M	$ -66.76M	$ -48.69M	$ 27.57M	$ 126.22M
Normalized Income	$ -20.68M	$ -52.73M	-	$ -35.37M	$ -44.33M
Interest Expense	-	-	-	$ 510.00K	$ 26.00K
EBIT	$ -52.47M	$ -61.80M	$ -45.05M	$ 28.14M	$ 126.27M
EBITDA	$ -44.84M	$ -58.63M	$ -49.05M	$ 32.15M	$ 130.20M

Currency in USD

RxSight Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing